These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Binding of mibolerone to androgen receptor of benign hypertrophic human prostate. Comparison with R1881. Akimoto S, Fuse H, Sato R, Zama S, Shimazaki J. Endocrinol Jpn; 1985 Feb; 32(1):141-52. PubMed ID: 2410244 [Abstract] [Full Text] [Related]
4. Binding of dihydrotestosterone, R 1881 and R 5020 in cytosols from normal, benign hypertrophic and cancerous human prostates. Nozumi K, Sato R, Ito H, Maruoka M, Shimazaki J. Urol Int; 1981 Feb; 36(2):79-87. PubMed ID: 6169181 [Abstract] [Full Text] [Related]
5. Androgen stimulated elevation in androgen receptor levels is inhibited by the synthetic glucocorticoid triamcinolone acetonide. Syms AJ, Norris JS, Smith RG. Biochem Biophys Res Commun; 1983 Nov 15; 116(3):1020-5. PubMed ID: 6606427 [Abstract] [Full Text] [Related]
6. Physicochemical characterization of the androgen receptor from hyperplastic human prostate. Murthy LR, Chang CH, Rowley DR, Scardino PT, Tindall DJ. Prostate; 1984 Nov 15; 5(6):567-79. PubMed ID: 6208540 [Abstract] [Full Text] [Related]
7. Cytoplasmic and nuclear androgen receptor content of normal and neoplastic human prostates and lymph node metastases of human prostatic adenocarcinoma. Shain SA, Boesel RW, Lamm DL, Radwin HM. J Clin Endocrinol Metab; 1980 Apr 15; 50(4):704-11. PubMed ID: 6154061 [No Abstract] [Full Text] [Related]
8. Binding of [3H]methyltrienolone to androgen receptor in rat liver. Kyakumoto S, Sato N, Nemoto T, Ohara-Nemoto Y, Ota M. Biochim Biophys Acta; 1984 Aug 21; 800(3):214-9. PubMed ID: 6331850 [Abstract] [Full Text] [Related]
9. Androgen receptor binding characteristics in the cytosol of the rat dorsolateral prostate gland and the Dunning R-3327 prostatic adenocarcinoma. Rowley DR, Thompson SA, Lubaroff DM, Heidger PM. Prostate; 1984 Aug 21; 5(1):101-11. PubMed ID: 6607463 [Abstract] [Full Text] [Related]
10. Specific binding of [3H]-methyltrienolone to both progestin and androgen binding components in human benign prostatic hypertrophy (BPH). Asselin J, Mélançon R, Gourdeau Y, Labrie F, Bonne C, Raynaud JP. J Steroid Biochem; 1979 May 21; 10(5):483-6. PubMed ID: 88546 [No Abstract] [Full Text] [Related]
11. Androgen receptor content of normal and hyperplastic human prostate. Trachtenberg J, Bujnovszky P, Walsh PC. J Clin Endocrinol Metab; 1982 Jan 21; 54(1):17-21. PubMed ID: 6172440 [Abstract] [Full Text] [Related]
12. Low molecular weight component of androgen receptor in cytosols from benign hypertrophic human prostate treated with high KCl solution. Kodama T, Fuse H, Shimazaki J. Endocrinol Jpn; 1982 Jun 21; 29(3):325-33. PubMed ID: 6184218 [Abstract] [Full Text] [Related]
13. Characterization and measurement of the androgen receptor in human benign prostatic hyperplasia and prostatic hyperplasia and prostatic carcinoma. Snochowski M, Pousette A, Ekman P, Bression D, Andersson L, Högberg B, Gustafsson JA. J Clin Endocrinol Metab; 1977 Nov 21; 45(5):920-30. PubMed ID: 72758 [No Abstract] [Full Text] [Related]
14. Concentration and cellular distribution of androgen receptor in human prostatic neoplasia: can estrogen treatment increase androgen receptor content? Mobbs BG, Johnson IE, Connolly JG, Thompson J. J Steroid Biochem; 1983 Sep 21; 19(3):1279-90. PubMed ID: 6604842 [Abstract] [Full Text] [Related]
15. Properties of progestin-binding protein in benign hypertrophic human prostate. Akimoto S, Sato R, Kodama T, Zama S, Fuse H, Shimazaki J. Endocrinol Jpn; 1986 Jun 21; 33(3):423-32. PubMed ID: 2428606 [Abstract] [Full Text] [Related]
16. Stabilization of androgen receptor by nonandrogenic steroids. Nemoto T, Ohara-Nemoto Y, Sato M, Ota M. Biochem Int; 1986 May 21; 12(5):701-5. PubMed ID: 3488063 [Abstract] [Full Text] [Related]
17. A hybrid ligand method for androgen receptor measurement. Stebbings WS, Anderson E, Puddefoot JR, Farthing MJ, Vinson GP. J Steroid Biochem; 1988 Aug 21; 31(2):181-6. PubMed ID: 2457134 [Abstract] [Full Text] [Related]
18. Receptor proteins for androgens in prostatic disease. Ghanadian R, Auf G, Chisholm GD, O'Donoghue EP. Br J Urol; 1978 Dec 21; 50(7):567-9. PubMed ID: 88985 [Abstract] [Full Text] [Related]
19. Binding of Permixon, a new treatment for prostatic benign hyperplasia, to the cytosolic androgen receptor in the rat prostate. Carilla E, Briley M, Fauran F, Sultan C, Duvilliers C. J Steroid Biochem; 1984 Jan 21; 20(1):521-3. PubMed ID: 6200701 [Abstract] [Full Text] [Related]
20. [Comparison of the binding nature of mibolerone to androgen receptor of human prostate with that of R1881]. Miki H, Oshimo K, Inoue H, Sumi T, Yamashita K, Morimoto T, Monden Y. Nihon Naibunpi Gakkai Zasshi; 1988 Aug 20; 64(8):655-65. PubMed ID: 3265669 [Abstract] [Full Text] [Related] Page: [Next] [New Search]